科研
教育
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Medical Sciences,
Section of Pharmacology,
and National Institute of Neurosciences,
Department of Medical Sciences, Section of Pharmacology, and National Institute of Neurosciences
Gianluca Verlengia has not added Biography.
If you are Gianluca Verlengia and would like to personalize this page please email our Author Liaison for assistance.
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders.
Neurobiology of disease Jul, 2013 | Pubmed ID: 23454193
Changes in the sensitivity of GABAA current rundown to drug treatments in a model of temporal lobe epilepsy.
Frontiers in cellular neuroscience , 2013 | Pubmed ID: 23874269
Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2015 | Pubmed ID: 25775541
Engineered HSV vector achieves safe long-term transgene expression in the central nervous system.
Scientific reports May, 2017 | Pubmed ID: 28473703
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes.
Molecular therapy. Methods & clinical development Sep, 2017 | Pubmed ID: 28702475
University of ferrara
Giovanna Paolone*,1,
Chiara Falcicchia*,1,
Gianluca Verlengia*,1,
Mario Barbieri1,
Anna Binaschi1,
Federico Paliotto1,
Beatrice Paradiso1,
Marie Soukupova1,
Silvia Zucchini1,2,
Michele Simonato1,2
1Department of Medical Sciences, Section of Pharmacology, and National Institute of Neurosciences, University of Ferrara,
2Laboratory for the Technologies for Advanced Therapies (LTTA), University of Ferrara
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。